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Abstract
Background: Plasma 25-hydroxyvitamin D (25(OH) D) deficiencies are associated with several diseases. The magnitude of
systemic inflammatory response, as evidenced by C-reactive protein (CRP), is a major factor associated with lower 25(OH)D.
Other aspects of the systemic inflammatory response may be important in determining plasma 25 (OH)D concentrations.
Aim: To examine the relationship between plasma 25(OH)D, CRP and albumin concentrations in two patient cohorts.
Methods: 5327 patients referred for nutritional assessment and 117 patients with critical illness were examined. Plasma 25
(OH) D concentrations were measured using standard methods. Intra and between assay imprecision was ,10%.
Result: In the large cohort, plasma 25 (OH) D was significantly associated with CRP (rs =20.113, p,0.001) and albumin
(rs = 0.192, p,0.001). 3711 patients had CRP concentrations#10 mg/L; with decreasing albumin concentrations$35, 25–34
and ,25 g/l, median concentrations of 25 (OH) D were significantly lower from 35 to 28 to 14 nmol/l (p,0.001). This
decrease was significant when albumin concentrations were reduced between 25–34 g/L (p,0.001) and when albumin ,
25 g/L (p,0.001). 1271 patients had CRP concentrations between 11–80 mg/L; with decreasing albumin concentrations $
35, 25–34 and ,25 g/l, median concentrations of 25 (OH) D were significantly lower from 31 to 24 to 19 nmol/l (p,0.001).
This decrease was significant when albumin concentration were 25–34 g/L (p,0.001) and when albumin ,25 g/L (p,
0.001). 345 patients had CRP concentrations .80 mg/L; with decreasing albumin concentrations $35, 25–34 and ,25 g/l,
median concentrations of 25 (OH) D were not significantly altered varying from 19 to 23 to 23 nmol/l. Similar relationships
were also obtained in the cohort of patients with critical illness.
Conclusion: Plasma concentrations of 25(OH) D were independently associated with both CRP and albumin and consistent
with the systemic inflammatory response as a major confounding factor in determining vitamin D status.
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Introduction
It has been recognised for some time that plasma 25-
hydroxyvitamin D (25(OH)D) deficiencies are associated with
increased risks of several diseases such as diabetes, hypertension,
stroke, and heart disease [1]. However, there is the potential for
confounding factors, since the presence of a systemic inflammatory
response has been consistently reported to be associated with low
plasma micronutrient concentrations [2–4]. In particular, it has
recently been reported that the magnitude of systemic inflamma-
tory response, as evidenced CRP, is a major factor associated with
the lowering of circulating concentrations of the important lipid
soluble vitamins such as 25(OH)D [5;6].
Duncan and co-workers [3] reported the presence of an
elevated systemic inflammatory response was associated with a
significant reduction (41%) in plasma vitamin D concentration
when CRP concentrations were .80 mg/L compared to #5 mg/
L. However, the variability of the association was such that plasma
25(OH)D concentrations were not readily adjusted for CRP
concentrations [3].
In the blood 25(OH)D is transported primarily bound to
vitamin D binding protein (VDBP) but also to albumin and these
fall as part of the systemic inflammatory response [5;6]. Albumin is
quantitatively the most important protein in the plasma and binds
most plasma micronutrients, including 25(OH) D. Moreover,
albumin may be considered as a surrogate measure for other
plasma binding proteins such as VDBP, and is routinely measured.
Therefore, it may be useful in adjusting plasma 25(OH) D
concentrations for the effect of the systemic inflammatory
response.
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The aim of the present study was to examine the relationships
between plasma 25(OH) D, CRP and albumin concentrations in a
large cohort of patients referred for vitamin D assessment and also
examine these relationships in patients with critical illness.
Patients and Methods
Nutritional Screen Cohort
A total of 7646 consecutive heparin-treated whole-blood
samples from 5327 patients were received from hospitals
throughout Scotland between January 2000 and March 2013 for
routine analysis of plasma 25 (OH) D concentrations. If more than
one set of plasma 25(OH) D results was available in a patient only
the first sample was included into the analysis, leaving a total of
5327 plasma 25(OH) D results. As a regional centre blood samples
were sent for analysis if the patient was considered at nutritional
risk and was often secondary to a number of disease states. In
addition, measurement of CRP and albumin was also recorded for
these patients.
Critical Illness Cohort
Patients in the intensive care unit (ICU) of the Royal Infirmary,
Glasgow who had respiratory failure requiring ventilatory support,
were $18 years old, and who had evidence of the systemic
inflammatory response syndrome as per Bone’s criteria [7;8], and
admitted in the period from September 2006 to December 2008
were studied. Briefly, APACHE II score [9] and predicted hospital
mortality and SOFA scores, CRP and albumin were recorded.
This cohort has been described previously and the purpose of this
cohort was to study micronutrients concentrations in the critically
ill [10].
This investigation was conducted with the intent of developing
local guideline to aid in the interpretation of vitamin 25 (OH) D
results. There were two cohorts studied. The first (a large
convenience retrospective sample) arose from an audit of patients
who had a sample sent to a regional laboratory for a nutritional
screen. The second (a small selected prospective cohort) arose from
a prospective study of patients with critical illness. The patient data
from the two cohorts was anonymized and de-identified prior to
analysis (AD and DCM respectively). In line with local ethical
procedures written informed consent was obtained for the latter
cohort only. The latter study was approved by the ethics
committees of the North Glasgow NHS Trust and Multicentre
Research Ethics Committee (MREC) Scotland. Where patients
were unable to give signed informed consent, consent was
obtained from the patients’ next of kin or welfare guardian in
accordance with the requirements of the Adults with Incapacity
Scotland (2000) Act.
Analytical Methods
Plasma 25 (OH) D was measured by enzyme immunoassay kit
(Immunodiagnostic Systems Ltd) until 2009, when tandem mass
spectrometry was used (Waters Acuity; UPLC and TQD). Using
routine standards and quality control, intra- and between assay
imprecision was ,10% in both methods over the concentration
range of 25 to 120 nmol/L. Both methods had a similar lower
limit of sensitivity of ,4 nmol/L.
CRP and albumin were measured using an automated analyzer
(Architect; Abbot Diagnosis, Maidenhead, UK). The limits of
detection for CRP and albumin were 0.2 mg/L and 10 g/L
respectively. The interassay CV was ,6% over the sample
concentration range for albumin and CRP.
Statistical Analysis
Data was presented in median and (range). Correlations
between variables in the control and critically-ill groups were
carried out using the Spearman rank correlation. The large cohort
was divided into three groups according to CRP concentrations #
10, 11–80 and .80 mg/L as previously described [11]. The
concentrations of individual 25 (OH) D were grouped according to
3 categories of albumin concentrations (#25, 25–34, $35 g/L) as
previously described [12]. For each albumin category data are
presented as medians and 5th, 10th, 25th, 75th, and 95th
percentiles. The concentration of each analyte was compared with
the reference albumin category of $35 g/L by using the Mann-
Whitney U test. With each CRP and albumin category the
Kruskal-Wallis test was used for the comparison of more than two
groups. A P- Value ,0.05 was considered significant and the
analysis of the data was carried out using SPSS software (version
19; SPSS Inc, Chicago, Ill).
Results
Nutritional Screen Cohort
The characteristics of the convenience sample (n = 5327) are
shown in Table 1. The majority were older than 50 years (median
58 years), female (67%) and had plasma CRP, albumin and 25
(OH) D in the normal range (median 31 mmol/l). Plasma 25 (OH)
D was significantly associated with age (rs = 0.052, p,0.001), sex
(males median 29 nmol/l, females median 33 nmol/l, p,0.001),
CRP (rs =20.113, p,0.001) and albumin (rs = 0.192, p,0.001).
Age was significantly associated with CRP (rs = 0.275, p,0.001)
and albumin (rs =20.292, p,0.001). CRP was significantly
associated with albumin (rs =20.496, p,0.001).
The association between the magnitude of the systemic
inflammatory response, as evidenced by CRP and albumin
concentrations, on 25 (OH) D are shown in Figure 1a and 1b.
The association of CRP and 25 (OH) D/albumin ratio is shown in
Figure 1c; the association of albumin and 25 (OH) D/CRP ratio is
shown in Figure 1d.
The median plasma concentrations of 25 (OH) D grouped
according to CRP concentrations #10, 11–80 and .80 mg/L
were 34, 27 and 22 nmol/l respectively (p,0.001) with an overall
reduction of 35%. The median plasma concentrations of 25 (OH)
D grouped according to albumin concentrations $35, 25–34 and
,25 g/l were 34, 25 and 20 nmol/l respectively (p,0.001) with
an overall reduction of 41%.
The median and the 5th, 10th, 25th, 75th, and 95th percentiles
of plasma 25 (OH) D concentrations grouped according to
albumin concentrations $35, 25–34 and ,25 g/l for CRP
concentrations #10, 11–80 and .80 mg/L are shown in
Table 2. 3711 patients had CRP concentrations #10 mg/L; with
decreasing albumin concentrations $35, 25–34 and ,25 g/l,
median plasma concentrations of 25 (OH) D were significantly
lower from 35 to 28 to 14 nmol/l (p,0.001). This decrease was
significant when albumin concentrations were between 25–34 g/L
(p,0.001) and when albumin concentrations were ,25 g/L (p,
0.001). 1271 patients had CRP concentrations between 11–
80 mg/L; with decreasing albumin concentrations $35, 25–34
and ,25 g/l, median plasma concentrations of 25 (OH) D were
significantly lower from 31 to 24 to 19 nmol/l (p,0.001). This
decrease was significant when albumin concentration were 25–
34 g/L (p,0.001) and when albumin concentrations were,25 g/
L (p,0.001). 345 patients had CRP concentrations .80 mg/L;
with decreasing albumin concentrations $35, 25–34 and,25 g/l,
median plasma concentrations of 25 (OH) D were not significantly
altered varying from 19 to 23 to 23 nmol/l.
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When albumin concentrations were $35 g/L, The median
plasma concentrations of 25 (OH) D grouped according to CRP
concentrations #10, 11–80 and .80 mg/L were 35, 31 and
19.0 nmol/l (p,0.001) with an overall reduction of 46%. When
albumin concentrations were 25–34 g/L, The median plasma
concentrations of 25 (OH) D grouped according to CRP
concentrations #10, 11–80 and .80 mg/L were 28, 24 and
23.0 nmol/l (p = 0.013) with an overall reduction of 18%. When
albumin concentrations were ,25 g/L, The median plasma
concentrations of 25 (OH) D grouped according to CRP
concentrations #10, 11–80 and .80 mg/L were 14, 19.0 and
23.0 nmol/l (p = 0.082). The median 25 (OH) D/albumin
ratio6100 for CRP concentrations #10, 11–80 and .80 mg/L
were 85.0, 84.2 and 90.9 (p = 0.002).
Patients with Critical Illness
The characteristics of the critically ill cohort (n = 117) are shown
in Table 3. The majority were older than 50 years (median 60
years), male (65%), an APACHE II score of 21 and SOFA score of
7 and the associated median predicted mortality was 34%. The
majority of patients were surgical (55%) and had a median length
of ICU stay of 5 days and median hospital stay of 22 days. The
median CRP and albumin concentrations were above and below
the normal reference intervals respectively. Median adjusted
calcium and median urea and creatinine concentrations were
Table 1. Characteristics of nutritional screen cohort and plasma 25 (OH) D concentrations.
Reference interval Nutritional screen cohort (n=5327)
Age (years) NA 58 (16–109)
Sex (Male/Female) NA 1773 (33%)/3554 (67%)
CRP (mg/l) ,10 5.0 (0.19–565.0)
Albumin (g/l) 35–55 38 (9–52)
25 (OH) D (nmol/l) ,25/25–50/.50 31 (6–1140)
(Median and range).
doi:10.1371/journal.pone.0092614.t001
Figure 1. 1a. The relationship between CRP (log 10) and 25 (OH) D in the nutritional screen cohort (rs=20.113, p,0.001). 1b. The relationship
between albumin and 25 (OH) D in the nutritional screen cohort (rs= 0.192, p,0.001). 1c. The relationship between CRP (log 10) and 25 (OH) D
adjusted to albumin in the nutritional screen cohort (rs=20.053, p,0.001). 1d. The relationship between albumin and 25 (OH) D adjusted to CRP in
the nutritional screen cohort (rs= 0.507, p,0.001).
doi:10.1371/journal.pone.0092614.g001
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within the normal reference interval. Approximately half had
some renal impairment eGFR of ,60 ml/min. The median
plasma 25(OH) D was 33 nmol/l. Plasma 25 (OH) D was
significantly associated with age (rs = 0.052, p,0.001), sex
(rs = 0.082, p,0.001), CRP (rs =20.113, p,0.001), albumin
(rs = 0.192, p,0.001). Age was significantly associated with sex
(rs = 0.030, p = 0.029), CRP (rs =20.275, p,0.001) and albumin
(rs =20.292, p,0.001). CRP was significantly associated with sex
(rs =20.040, p = 0.003) albumin (rs =20.496, p,0.001).
The association between the magnitude of the systemic
inflammatory response, as evidenced by CRP and albumin
concentrations, on 25 (OH) D in patients with critical illness are
shown in Figure 2a and 2b. The association of CRP and 25 (OH)
D/albumin ratio is shown in Figure 2c; the association of albumin
and 25 (OH) D/CRP ratio is shown in Figure 2d.
Discussion
The results of the present study show that, in two different
patient cohorts, plasma concentrations of 25(OH) D were
associated with the magnitude of the systemic inflammatory
response as evidenced by both changes in CRP and albumin
concentrations. This effect was differential with CRP most strongly
associated with a reduction in plasma 25(OH) D where albumin
concentrations were in the normal range (.35 g/l) and with a
much weaker association where albumin concentrations were very
low (,25 g/l). With normal CRP concentrations (#10 mg/L),
albumin had an independent effect on plasma concentrations of
25(OH) D. These results provide a basis for the better
understanding of the impact of the systemic inflammatory
response on plasma vitamin D concentrations and for their
assessment and interpretation.
There is now wealth of data from observational studies that
have shown associations between low concentrations of plasma
25(OH) D and increased risk of cardiovascular disease, cancer,
neurodegenerative diseases, disorders of glucose metabolism and
death. Many factors such as ageing, ethnicity, season, latitude,
adiposity, physical activity, smoking and diet may impact on the
link between low 25(OH) D and the above health outcomes. In the
present study of patients referred for a nutritional screen some or
all of the above factors may have impacted on plasma 25(OH) D
concentrations. However, all of the above potential confounding
factors appear to be dependent on inflammatory processes for
their effect on plasma 25(OH) D concentrations. This is well
illustrated in a recent study of the effect of elective knee
arthroplasty on plasma 25(OH) D concentrations [5]. Indeed,
inflammatory processes have been proposed as a major reason
behind the discrepancy in effect of normal vs deficient plasma
25(OH) D concentrations on health outcomes in observational
studies (beneficial effect) and interventional (no effect) studies of
health outcomes [13]. The similar associations seen in the critical
illness cohort in the present study are also consistent with such a
concept.
In the present study, the basis of the relatively low median
plasma concentrations of 25(OH) D concentrations in those
patients with normal C-reactive protein and albumin concentra-
tions is not clear. However, at northerly latitudes such as Scotland
plasma concentrations of 25(OH) D concentrations are lower [14].
Indeed, it is recognized that the majority of the Scottish population
have plasma 25(OH) D concentrations less than 50 nmol/l
considered to be borderline vitamin D status [14]. In such patients
with albumin concentrations in the normal range the basis of the
inverse relationship between CRP and plasma 25(OH) D might be
due to consumption of vitamin D since the concentrations of other
binding proteins such as VDBP are also likely to be in the normal
range [5;6]. Also, there is some evidence that 25(OH)D can be
actively taken up by inflammatory cells, particularly macrophages
[15]. In contrast, in those patients with low plasma albumin
concentrations the lack of such a relationship between CRP and
plasma 25(OH) D might be due to loss of vitamin D from the
plasma compartment due to redistribution of its binding proteins
vitamin D binding protein and albumin [5]. More generally the
associations of plasma concentrations of C-reactive, albumin and
vitamin D may reflect the redistribution and or consumption of
body stores by a chronic ongoing systemic inflammatory response.
If this were the case it is likely that similar associations would apply
to other micronutrients.
In order to confirm whether the combination of CRP and
albumin can better account for the variability of plasma of
25(OH)D it would be important to have access to direct
intracellular measurements. For example, red blood cells have
been shown to be useful for vitamin B6, vitamin E, B2 zinc and
selenium concentrations in subjects undergoing an elective knee
arthroplasty with a consequent acute systemic inflammatory
response [16–18] and in patients with critical illness [10;19–21].
Whereas plasma concentrations of these vitamins deceased rapidly
on activation of the systemic inflammatory response, red blood cell
concentrations remained stable. Therefore, alongside the present
measurements of plasma 25(OH)D, CRP and albumin concen-
trations it would be important to examine intracellular concen-
trations of 25(OH)D to better inform the effect of CRP and
albumin on plasma 25(OH)D. Also, this may provide insight into
the nature of the effect i.e. whether redistribution or consumption.
In summary, it is now recognized that plasma concentrations of
25(OH)D are confounded in the presence of a systemic
inflammatory response, as evidenced by CRP. The results of the
present study show that albumin concentration also has an
independent effect on plasma concentrations of 25(OH)D.
Therefore, plasma concentrations of 25(OH)D may not be reliably
interpreted in the presence of abnormal CRP (.10 mg/l) and
Table 3. Characteristics of ICU cohort and plasma vitamin D concentrations.
Reference interval Nutritional screen cohort (n=117)
Age (years) NA 60 (18–100)
Sex (Male/Female) NA 76 (65%)/41 (35%)
C-reactive protein (mg/l) ,10 109.0 (1.0–565.0)
Albumin (g/l) 35–55 17 (9–45)
25 (OH) D (nmol/l) ,25/25–50/.50 33 (13–1140)
(Median and range).
doi:10.1371/journal.pone.0092614.t003
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albumin concentrations (,35 g/l). It may be that plasma
concentrations of 25(OH)D in the presence of normal C-reactive
and albumin concentrations reliably indicate nutritional status of
vitamin D and the need for supplementation.
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